InvestorsHub Logo
Followers 17
Posts 4048
Boards Moderated 0
Alias Born 01/12/2004

Re: None

Thursday, 01/04/2018 4:47:38 PM

Thursday, January 04, 2018 4:47:38 PM

Post# of 665
"late December 2017 or early January 2018" Clock is ticking!

Biotech Showcase 2018 on Jan. 9, but if the information was material, they couldn't just sit on it until then, right?

Hopefully with all of AXSM's irons in the fire, they will have something for us soon. Nice to see a little green pop today.
Website needs updated with AXS-07!


AXS-02 CREATE-1
Complex regional pain syndrome (CRPS)
Phase 3 Initiated July 2015. Interim efficacy analysis due late December 2017 or early January 2018.

AXS-02 COAST-1
Knee Osteoarthritis Associated with Bone Marrow Lesions
Phase 3 Phase 3 commenced March 2016. Interim efficacy analysis due late December 2017 or early January 2018.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXSM News